Go online to PeerView.com/VGX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in malignant pleural mesothelioma discuss tumor treating fields and novel systemic approaches to optimize patient outcomes. Upon completion of this activity, participants will be able to: Describe the rationale for use of tumor treating fields (TTFields), antiangiogenic strategies, and immunotherapeutic approaches in the management of malignant pleural mesothelioma (MPM), Discuss the latest efficacy and safety evidence on TTFields, angiokinase inhibitors, immune checkpoint inhibitors, and combination strategies in different MPM settings, Employ appropriate strategies to monitor for and manage treatment-emergent adverse events in patients with MPM receiving TTFields or other novel therapies, Recommend TTFields and other emerging systemic options appropriately, in the context of clinical trials or as they become available for daily practice, for eligible patients with MPM.
View all episodes
